NYSE ARCA | ETF
The fund is actively managed and seeks to invest primarily in equity securities selected from a universe of developed market equities, excluding the United States and Canada, that exhibit value characteristics based on the selection results of a proprietary, quantitative artificial intelligence ("AI") model developed by Sub-Adviser.
The equity securities selected by the AI model typically have a lower price-to-book ratio, a lower price-to-earnings ratio, and greater free cash flow.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ZURN | Zurich Insurance Group AG | Financial Services | Insurance - Diversified | 3.65% |
| BATS | British American Tobacco PLC | Consumer Defensive | Tobacco | 3.62% |
| DG | Vinci S.A. | Industrials | Engineering & Construction | 3.41% |
| BAS | BASF SE | Basic Materials | Chemicals | 3.35% |
| MBG | Mercedes-Benz Group AG | Consumer Cyclical | Auto Manufacturers | 3.31% |
| 5108 | Bridgestone Corp. | Consumer Cyclical | Auto Parts | 3.27% |
| TCL | Transurban Group | Industrials | Infrastructure Operations | 3.24% |
| SWED-A | Swedbank AB (publ) | Financial Services | Banks - Regional | 3.18% |
| UU | United Utilities Group PLC | Utilities | Utilities - Regulated Water | 3.12% |
| MNG | M&G Plc | Financial Services | Asset Management | 3.08% |
| ENG | Enagás S.A. | Utilities | Utilities - Regulated Gas | 2.74% |
| GBLB | Groep Brussel Lambert NV | Financial Services | Asset Management | 2.67% |
| IMB | Imperial Brands PLC | Consumer Defensive | Tobacco | 2.50% |
| SREN | Swiss Re AG | Financial Services | Insurance - Reinsurance | 2.22% |
| 5201 | AGC Inc | Industrials | Conglomerates | 2.19% |
| PST | Poste Italiane SpA | Industrials | Conglomerates | 2.15% |
| 8630 | Sompo Holdings Inc | Financial Services | Insurance - Property & Casualty | 2.14% |
| BA | BAE Systems plc | Industrials | Aerospace & Defense | 2.09% |
| BAYN | Bayer AG NA | Healthcare | Drug Manufacturers - General | 2.07% |
| 4502 | Takeda Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | 2.06% |